**Biggest Losers Among (June 17, 2026)** # 1. INLF (INLIF Limited) — -50% to -68% * Trading in the low $1–$2 range intraday. * **Why?** Sharp reversal after recent positive news (e.g., $4.4M order for battery cell packing machines in …
# Top Winners * **SNBR (Sleep Number Corporation)**: **+242%** (trading around $0.60 range) **Why?** Extreme volatility following the company's recent Chapter 11 bankruptcy filing and asset purchase agreement with Sleep Country Canada. This appears to be a short squeeze or …
AIMD bouncing off these levels after today's news on: New research program with National Taiwan University taking Smell AI from environmental/industrial sensing into digital breath intelligence for dyspneic patients in emergency settings. Low float micro-cap with real traction building on …
⚙️ $LBRG continues to showcase why JingDiao is becoming a critical player in advanced manufacturing. ◉ 18-meter industrial laser cutting capabilities ◉ Precision machining with advanced 5-axis CNC systems ◉ Supports complex EV production lines and giga-casting infrastructure ◉ …
Another government contract comes out, this time with $3 million in ARR. That's 30% of their current amount and completely changes the game - they were on the verge of bankruptcy last week and now they are back in it. …
LAS VEGAS, June 17, 2026 (GLOBE NEWSWIRE) -- **Asia Broadband Inc. (OTC: AABB)** ("AABB" or the "Company") is pleased to report that the Company has completed an acquisition of two land parcels that sit adjacent to the Company's Etzatlan gold …
Putting this out there for the small-cap/Nordic crowd. FSport AB is a Swedish gaming and media company out of Helsingborg, founded in 2013. They run a Daily Fantasy Sports platform (fsport.se), plus affiliate gaming portals (1X2.se, Trav.se) and a hockey-betting …
Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
Outlook Therapeutics (OTLK) is a one-drug biotech. The drug is LYTENAVA, an eye-injection version of bevacizumab for wet AMD, a leading cause of vision loss in older patients. The whole company resolves to a single date: July 29, 2026, the …
You may or may not have heard that Uranium is a heavily overlooked sector right now. Despite a severe global supply crunch, U.S. bans on Russian fuel, and growing electricity demand from AI, uranium stocks have been run down hard. …